OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Subtle immunological differences in mRNA-1273 and BNT162b2 COVID-19 vaccine induced Fc-functional profiles
Paulina Kapłonek, Deniz Cizmeci, Stephanie Fischinger, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 15

Showing 15 citing articles:

Correlates of protection against SARSCoV‐2 infection and COVID‐19 disease
David Goldblatt, Galit Alter, Shane Crotty, et al.
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 6-26
Open Access | Times Cited: 233

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong
Chris Ka Pun Mok, Carolyn A. Cohen, Samuel M. S. Cheng, et al.
Respirology (2021) Vol. 27, Iss. 4, pp. 301-310
Open Access | Times Cited: 149

SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivity
Simone I. Richardson, Nelia P. Manamela, Boitumelo M. Motsoeneng, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100510-100510
Open Access | Times Cited: 74

Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
Jeffrey Tomalka, Mehul S. Suthar, Steven G. Deeks, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 360-370
Open Access | Times Cited: 38

Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus in serum of mRNA-vaccinated individuals receiving tumor necrosis factor-α inhibitors
Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, et al.
Med (2021) Vol. 2, Iss. 12, pp. 1327-1341.e4
Open Access | Times Cited: 36

Distinct Homologous and Variant-Specific Memory B-Cell and Antibody Response Over Time After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccination
Iana H. Haralambieva, Jonathon M. Monroe, Inna G. Ovsyannikova, et al.
The Journal of Infectious Diseases (2022) Vol. 226, Iss. 1, pp. 23-31
Open Access | Times Cited: 17

Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID-19 Vaccines in Hong Kong
Chris Ka Pun Mok, Carolyn A. Cohen, Samuel M. S. Cheng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 21

Comprehensive antibody profiling of mRNA vaccination in children
Yannic C. Bartsch, Kerri St. Denis, Paulina Kapłonek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 16

Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients
Frédéric Baron, Lorenzo Canti, Kevin K. Ariën, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10

In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Multiple Sclerosis and Related Disorders (2023) Vol. 72, pp. 104616-104616
Open Access | Times Cited: 4

A Glimpse for the subsistence from pandemic SARS-CoV-2 infection
Santosh Kumar Rath, Ashutosh K. Dash, Nandan Sarkar, et al.
Bioorganic Chemistry (2024) Vol. 154, pp. 107977-107977
Closed Access

BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children
Yannic C. Bartsch, Jessica W. Chen, Jaewon Kang, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2

Reduced antibody activity against SARS-CoV-2 B.1.617.2 Delta virus in serum of mRNA-vaccinated patients receiving TNF-α inhibitors
Rita E. Chen, Matthew J. Gorman, Daniel Y. Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

A SARS-CoV-2 variant of concern triggers Fc effector function with increased cross-reactivity
Simone I. Richardson, Nelia P. Manamela, Boitumelo M. Motsoeneng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

Maternal immune response and placental antibody transfer after COVID-19 vaccination across trimester and platforms
Caroline Atyeo, Lydia L. Shook, Sara Brigida, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 2

Page 1

Scroll to top